financetom
Business
financetom
/
Business
/
Skyward Specialty Q3 net income rises 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Skyward Specialty Q3 net income rises 
Oct 29, 2025 1:28 PM

Overview

* Skyward Specialty Q3 net income rises to $45.9 mln, up from $36.7 mln in 2024

* Gross written premiums increase 51.6% yr/yr, driven by agriculture and credit (re)insurance

* Company achieves Q3 combined ratio of 89.2%, indicating improved underwriting performance

Outlook

* Company expects Apollo acquisition to close early next year

* Skyward Specialty confident in outlook for remainder of year

Result Drivers

* PREMIUM GROWTH - Gross written premiums rose 51.6%, driven by agriculture and credit (re)insurance division

* COMBINED RATIO IMPROVEMENT - Achieved a Company-best combined ratio of 89.2%, reflecting improved underwriting performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Gross $606.50

written mln

premiums

Q3 EPS $1.10

Q3 Net $45.90

Income mln

Q3 $44 mln

Adjusted

Operatin

g Income

Q3 89.20%

Combined

Ratio

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the property & casualty insurance peer group is "buy"

* Wall Street's median 12-month price target for Skyward Specialty Insurance Group Inc ( SKWD ) is $62.00, about 27.2% above its October 28 closing price of $45.14

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil soybean, cotton traders join other lobbies against tax rule change
Brazil soybean, cotton traders join other lobbies against tax rule change
Jun 6, 2024
SAO PAULO, June 6 (Reuters) - Brazilian soybean and cotton companies on Thursday joined the biofuels and food lobbies to blast new rules for use of tax credits, increasing the odds the measure will be rejected by a Congress heavily influenced by farming interests. Backlash for the measure represents the latest test in President Luiz Inacio Lula da Silva's shaky...
National Bank Maintains Transat Underperform Rating, $2.25 Target After Q2 Result
National Bank Maintains Transat Underperform Rating, $2.25 Target After Q2 Result
Jun 6, 2024
01:47 PM EDT, 06/06/2024 (MT Newswires) -- National Bank is maintaining its Underperform rating and $2.25 target on Transat following its second quarter results. Analyst Cameron Doerksen writes that in mid-May, Transat lowered its F2024 EBITDA margin expectation to ~5% from prior guidance of 7.5%-9% driven by challenges related to engine-related aircraft groundings, the impact from strike threats, and generally...
Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial
Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial
Jun 6, 2024
01:49 PM EDT, 06/06/2024 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Thursday data from a phase 2a trial in patients with chronic hepatitis B virus infection showed that treatment with imdusiran followed by Barinthus Biotherapeutics' ( BRNS ) VTP-300 was generally safe and well-tolerated. Based on preliminary end-of-treatment data, Arbutus said that the therapy resulted in maintenance of...
Exclusive-Chile's Codelco targeting 2030 production for Maricunga lithium site -document
Exclusive-Chile's Codelco targeting 2030 production for Maricunga lithium site -document
Jun 6, 2024
SANTIAGO (Reuters) - Rothschild & Co has formally started to assess candidates to partner with Chile's state-run miner Codelco on a major new lithium project slated to begin production in 2030, according to documents seen by Reuters on Thursday. A four-page investment highlight document from Codelco and Rothschild, dated June 2024, and accompanying memo, reveal new details of Codelco's plans...
Copyright 2023-2026 - www.financetom.com All Rights Reserved